Alpha Teknova (TKNO) Shares Outstanding (Weighted Average) (2020 - 2026)
Alpha Teknova (TKNO) reported Shares Outstanding (Weighted Average) of $53.6 million for Q1 2026, little changed year-over-year from $53.4 million in Q1 2025, and little changed quarter-over-quarter from $53.5 million in Q4 2025.
Alpha Teknova (TKNO) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $53.6 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $53.6 million, changed 0.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.6 million (changed 0.35% YoY), and the FY2025 annual result was $53.5 million, up 14.41% from the prior year.
- Shares Outstanding (Weighted Average) was little changed at $53.6 million in Q1 2026 per TKNO's latest filing, from $53.5 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $53.6 million in Q1 2026 and troughed at $28.0 million in Q1 2022.
- A 5-year average of $39.4 million and a median of $40.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 678.8% in 2022 and fell as far as 0.28% in 2022.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $28.1 million in 2022, then rose by 13.3% to $31.8 million in 2023, then surged by 46.91% to $46.7 million in 2024, then grew by 14.41% to $53.5 million in 2025, then gained by 0.23% to $53.6 million in 2026.
- Business Quant data shows TKNO's Shares Outstanding (Weighted Average) at $53.6 million in Q1 2026, $53.5 million in Q4 2025, and $53.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Alpha Teknova | 249.27 Mn | 231.49 Mn | 3.78 Mn | 53.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.61 Mn |
| Dec 31, 2025 | 53.48 Mn |
| Sep 30, 2025 | 53.46 Mn |
| Jun 30, 2025 | 53.45 Mn |
| Mar 31, 2025 | 53.42 Mn |
| Dec 31, 2024 | 46.75 Mn |
| Sep 30, 2024 | 44.52 Mn |
| Jun 30, 2024 | 40.85 Mn |
| Mar 31, 2024 | 40.80 Mn |
| Dec 31, 2023 | 31.82 Mn |
| Sep 30, 2023 | 28.81 Mn |
| Jun 30, 2023 | 28.27 Mn |
| Mar 31, 2023 | 28.18 Mn |
| Dec 31, 2022 | 28.08 Mn |
| Sep 30, 2022 | 28.09 Mn |
| Jun 30, 2022 | 28.04 Mn |
| Mar 31, 2022 | 28.03 Mn |
| Dec 31, 2021 | 16.09 Mn |
| Sep 30, 2021 | 28.01 Mn |
| Jun 30, 2021 | 3.97 Mn |